Fideuram Asset Management (Ireland) dac

Position in NBIX — Neurocrine Biosciences Inc

CIK 2109923 DUBLIN 1, L2

Back to NBIX Full portfolio

Position in NBIX

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$829,553

+$826,859 QoQ

Shares Held

4,922

+25805.3% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#424

of 768 holders

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Fideuram Asset Management (Ireland) dac holds $17,140,473 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (4.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	142,079	$10,209,796
2	TEVA	Teva Pharmaceutical Industries Ltd	113,775	$3,854,697
3	UTHR	UNITED THERAPEUTICS Corp	4,146	$2,246,427
4	NBIX	Neurocrine Biosciences Inc This page	4,922	$829,553

All Filings in NBIX

Export CSV

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$829,553	4,922	+25805.3%	Shares	Other	2026-07-23
2025-12-31	$2,694	19	—	Shares	Other	2026-02-10
No filing history on record for this holder in this stock.